Abano Healthcare Group Limited reported unaudited consolidated earnings results for the six months ended November 30, 2017. For the period, the company reported revenue if NZD 133,213,000 against NZD 116,809,000 a year ago. Operating profit was NZD 12,081,000 against NZD 11,262,000 a year ago. Profit before income tax was NZD 9,305,000 against NZD 8,606,000 a year ago. Profit for the period attributable to equity holders of the company share of profit was NZD 6,001,000 against NZD 5,874,000 a year ago. Earnings per share were 25.40 cents against 27.48 cents a year ago. Net cash generated from operating activities was NZD 12,057,000 against NZD 8,416,000 a year ago. Purchase of property, plant, equipment and intangible assets were NZD 8,871,000 against NZD 5,425,000 a year ago. EBITDA was NZD 17.9 million against NZD 16.5 million a year ago. Underlying EBITDA was NZD 18.3 million against NZD 16.8 million a year ago. Underlying NPAT was 6.7 million against NZD 6.3 million a year ago. NPAT was NZD 6.0 million against NZD 5.9 million a year ago. Net Assets per Security was NZD 6.64 against NZD 5.51 a year ago.